Zepbound's published list price is about $1,059 per month as of April 2026, but insurance, the prescribed indication, savings cards, and pharmacy coupons all reshape that figure. This overview explains each factor and the genetic context PlexusDx places upstream of any protocol.

A clear look at how Ozempic coupons work in 2026: the manufacturer savings card, third-party discount platforms, how insurance status changes their value, the list price behind the discount, and the compounded alternative pathway.

Searching for a Wegovy pill leads somewhere unexpected: the injection has no tablet form. This guide explains the oral GLP-1 products that genuinely exist, why swallowing a peptide is difficult, how a pill compares with the weekly shot, and where your genetics fit.

Mounjaro (tirzepatide, Eli Lilly) is a GLP-1 receptor agonist with a well-characterized safety profile. This article covers common side effects, serious warnings, the boxed-warning context, and when to call a provider — plus the genetic variables that shape baseline GLP-1 biology.

Genetic peptide testing analyzes how your DNA shapes 14 biological pathways that peptide protocols target — from GLP-1 signaling to growth hormone axis to estrogen clearance. The PlexusDx Precision Peptide Genetic Test delivers 150+ insights across 49 unique peptides, turning peptide decisions from guesswork into evidence-based conversations with your healthcare provider.

The PlexusDx Precision Peptide Genetic Test analyzes 34 weight management genetic insights — covering 8 peptide pathways, 11 SNPs, and 9 genes including FTO, MC4R, PPARG, TCF7L2, and GIPR. This comprehensive guide explains what each insight cluster covers, which peptide pathways are analyzed, and why genetic specificity is the missing variable in most weight management decisions.

In April 2026, a Nature GWAS of 27,885 GLP-1 medication users found GIPR rs1800437 associated with outcomes specifically in tirzepatide users — not in GLP-1-only agonist users. This article explains what that finding means, why the dual-receptor distinction matters, and why the PlexusDx Precision Peptide Genetic Test directly genotypes this SNP across 34 weight management insights.

The PlexusDx Precision Peptide Genetic Test analyzes 34 weight management genetic insights — including the pathways most relevant to GLP-1 receptor signaling. This article explains what the research shows about genetics and semaglutide response, why MTHFR methylation status matters in the broader metabolic picture, and how genetic testing can help inform a smarter weight management approach.

The PlexusDx Precision Peptide Genetic Test analyzes 34 weight management genetic insights — including GLP-1 receptor signaling and GIPR response pathways. This article explains how genes like FTO, MC4R, and PPARG influence appetite, fat metabolism, and weight regulation, and why your DNA may be the most underused variable in any weight management decision.